Abstract Details

�鶹��ýӳ��

Abstract Details

Title The Impact of Surgical Treatment on the Driving Status of Adults with Refractory Epilepsy

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) Epilepsy/Clinical Neurophysiology (EEG) Posters (7:00 AM-5:00 PM)

Poster/Presentation
Number 108

Objective

To investigate driving status as an outcome of epilepsy surgery in adults with epilepsy (AWE).

Background

Epilepsy surgery outcomes generally focus on seizure control. We studied driving status as an outcome of respective surgery in AWE.

Design/Methods AWE who underwent VEEG (1998-2003) were invited to participate in a long-term study investigating functional outcomes including driving status. Subjects completed questionnaires, validated in a subpopulation, during VEEG at baseline and at serial time points. Driving status was self-reported. Seizure status was recorded in a standardized template pre- and post-operatively in the electronic health record. McNemar’s test was used to compare the percent of subjects driving between time points. Analysis was performed using SAS software.

Results

92 subjects (56.5% female, median age 36.0 (16.0, 57.0)) were included with a median follow-up of 8 yr (0.89-17.4). Median monthly frequency of disabling seizures was 5.0 (0.00, 250.0) at baseline and 0.00 (0.00, 90.0) at follow-up. 64 (69.6%) subjects self-reported driving status at both time points. Of these, 22 (34%) did not drive at either time point, 11 (17%) drove at both time points, 4 (6%) reported driving only at baseline, and 27 (42%) reported driving only at follow-up visit. The change in driving was significant (p<0.001), and remained significant even among those who were not entirely seizure free post-operatively (p<0.001).

Conclusions Driving status improves in AWE after epilepsy surgery in those who report it.

Authors/Disclosures
Amanda Bingaman PRESENTER	Ms. Bingaman has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Nancy R. Foldvary-Schaefer, DO, F�鶹��ýӳ�� (Cleveland Clinic)	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.